Dr. Reddy's Laboratories Faces Short-Term Challenges Amidst Strong Long-Term Growth Potential
Dr. Reddy's Laboratories has shown mixed performance in the market, maintaining a stable price despite recent gains. With a market cap of Rs 1,05,027.94 crore and a P/E ratio significantly below the industry average, the stock has declined over the past year but outperformed the Sensex over three years.
Dr. Reddy's Laboratories, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced notable activity today, reflecting a complex market landscape. The stock opened at Rs 1254.7 and has maintained this price throughout the trading session. Despite a recent trend of seven consecutive days of gains, the stock has underperformed the sector by 0.98%, indicating a potential trend reversal.With a market capitalization of Rs 1,05,027.94 crore, Dr. Reddy's Laboratories holds a P/E ratio of 18.57, significantly lower than the industry average of 35.43. This suggests a valuation that may attract attention in the context of its peers.
In terms of performance metrics, the stock has shown a mixed bag over various time frames. Over the past year, it has declined by 8.94%, contrasting with the Sensex's modest gain of 1.26%. However, on a three-year horizon, Dr. Reddy's Laboratories has outperformed the Sensex with a remarkable growth of 49.82%.
Overall, while the stock faces challenges in the short term, its long-term performance remains robust compared to the broader market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
